Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity
-
- Thomas A. Wadden
- Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia
-
- Timothy S. Bailey
- AMCR Institute, Escondido, California
-
- Liana K. Billings
- Department of Medicine, NorthShore University HealthSystem/University of Chicago Pritzker School of Medicine, Skokie, Illinois
-
- Melanie Davies
- Diabetes Research Centre, University of Leicester, Leicester, United Kingdom
-
- Juan P. Frias
- National Research Institute, Los Angeles, California
-
- Anna Koroleva
- Novo Nordisk A/S, Søborg, Denmark
-
- Ildiko Lingvay
- Departments of Internal Medicine/Endocrinology and Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas
-
- Patrick M. O’Neil
- Weight Management Center, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston
-
- Domenica M. Rubino
- Washington Center for Weight Management and Research, Arlington, Virginia
-
- Dorthe Skovgaard
- Novo Nordisk A/S, Søborg, Denmark
-
- Signe O. R. Wallenstein
- Novo Nordisk A/S, Søborg, Denmark
-
- W. Timothy Garvey
- Department of Nutrition Sciences, University of Alabama at Birmingham
書誌事項
- タイトル別名
-
- The STEP 3 Randomized Clinical Trial
収録刊行物
-
- JAMA
-
JAMA 325 (14), 1403-, 2021-04-13
American Medical Association (AMA)